Cat allergies are a common and costly problem in the United States. Various drug and nondrug therapies exist to alleviate and control symptoms once allergic disease has developed. However, these therapies are often ineffective or do not address the underlying condition itself. Immunotherapy is an option for patients when symptoms are not adequately controlled by medications and/or avoidance measures, when adverse effects of medications are unacceptable, or when the patient wants to reduce their long-term use of medication. The purpose of this article is to describe the efficacy and safety of immunotherapy when used to prevent or treat cat allergies.
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2026.
All research outputs
#12,425,845
of 34,518,147 outputs
Outputs from American Journal of Lifestyle Medicine
#542
of 952 outputs
Outputs of similar age
#146,365
of 355,012 outputs
Outputs of similar age from American Journal of Lifestyle Medicine
#13
of 20 outputs
Altmetric has tracked 34,518,147 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 952 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.5. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,012 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.